Published in Br J Cancer on December 01, 1992
Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. Br J Cancer (1994) 1.12
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer. Clin Exp Immunol (1995) 0.82
Pretreatment serum CRP and response to interleukin 2. Br J Cancer (1994) 0.80
In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses. Br J Cancer (1994) 0.80
Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines. Br J Cancer (1997) 0.76
Interleukin-1. Rev Infect Dis (1984) 11.24
The phenomenon of the acute phase response. Ann N Y Acad Sci (1982) 6.14
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg (1989) 3.58
Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med (1987) 3.48
A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem (1977) 1.81
Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells. J Biol Chem (1987) 1.60
IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol (1989) 1.47
Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol (1984) 1.38
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor. Cancer Res (1990) 1.14
Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J Surg (2001) 4.72
A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med (1989) 2.63
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
Validation of a short questionnaire for estimating dietary calcium intakes. Osteoporos Int (2014) 2.06
The role of glucose limitation in the regulation of the transport of glucose, gluconate and 2-oxogluconate, and of glucose metabolism in Pseudomonas aeruginosa. J Gen Microbiol (1976) 2.01
Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb (1996) 2.00
Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies. Lancet (1990) 1.80
Long-term survival of HeLa tumours in mice treated with antilymphocyte serum. Br J Cancer (1973) 1.69
Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? Br Med J (Clin Res Ed) (1982) 1.69
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol (2000) 1.69
Glomus tumour: an analysis of 43 patients and review of the literature. Br J Surg (1992) 1.68
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
A trial of family therapy v. a relatives group for schizophrenia. Br J Psychiatry (1989) 1.59
Self-expanding metal stents in the management of colorectal carcinoma--a preliminary report. Clin Radiol (1998) 1.56
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol (1992) 1.50
Surgical management of the septic complications of diverticular disease. Ann R Coll Surg Engl (1995) 1.44
Accuracy of laparoscopic ultrasonography in the staging of upper gastrointestinal malignancy. Br J Surg (1996) 1.43
Comparison of the direct antiglobulin rosetting reaction with the mixed antiglobulin rosetting reaction for the detection of immunoglobulin on lymphocytes. J Immunol Methods (1977) 1.42
Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid. Eur J Surg Oncol (1999) 1.41
Vaccination therapy in malignant disease. Surgeon (2006) 1.40
Safety of fibreoptic endoscopy: analysis of cardiorespiratory events. Br J Surg (1992) 1.39
Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg (1999) 1.38
Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal. Transplantation (1981) 1.38
Toxicity of the immune suppressant cyclosporin A in the rat. J Pathol (1982) 1.38
Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study. Mol Biother (1990) 1.37
Serum and urine N-acetyl-beta-D-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics. Clin Chim Acta (1979) 1.36
The regulation of transport of glucose, gluconate and 2-oxogluconate and of glucose catabolism in Pseudomonas aeruginosa. Biochem J (1976) 1.34
Natural killer cells and cancer. Cancer (1996) 1.33
Cognitive performance and mood after a weekend on call in a surgical unit. Br J Surg (1997) 1.30
Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes. Biochem J (1977) 1.30
The effect of sex hormones on peripheral immunity in patients with advanced breast cancer. Clin Oncol (1978) 1.26
Varicocoele caused by a pancreatic pseudocyst. Gut (1983) 1.21
The effect of chronic diabetes, induced by streptozotocin, on the activities of some enzymes of glycerolipid synthesis in rat liver. Biochem J (1977) 1.19
The Combat Exposure Scale: a systematic assessment of trauma in the Vietnam War. J Clin Psychol (1984) 1.19
Mucosal changes in the large bowel with endometriosis: a possible cause of misdiagnosis of colitis? Hum Pathol (1994) 1.16
Nutrition and malignant disease: implications for surgical practice. Br J Surg (1992) 1.15
The effect of sex hormones on the growth of HeLa tumour nodules in male and female mice. Br J Cancer (1975) 1.15
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor. Cancer Res (1990) 1.14
Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions (1984) 1.14
Experimental cyclosporin A nephrotoxicity. Br J Exp Pathol (1982) 1.12
Hidden dangers of sliced bread. Br Med J (Clin Res Ed) (1984) 1.12
The accuracy of "one-stop" diagnosis for 1,110 patients presenting to a symptomatic breast clinic. J R Coll Surg Edinb (1999) 1.11
The effects of smoking on fracture healing. Surgeon (2010) 1.11
Cyclosporine-induced fetotoxicity in the rat. Transplantation (1985) 1.10
BMX bicycle injuries in children. Injury (1986) 1.10
Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes. Biochem J (1979) 1.10
Effects of a non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage. Br J Sports Med (1988) 1.09
FK 506 inhibition of cyclosporine metabolism by human liver microsomes. Transplant Proc (1991) 1.09
Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb (2000) 1.09
Breast cancer in women aged 35 and under: prognosis and survival. J R Coll Surg Edinb (2002) 1.09
Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci (Lond) (1993) 1.08
T and B lymphocyte populations in human normal lymph node, regional tumour lymph node and inflammatory lymph node. Int Arch Allergy Appl Immunol (1976) 1.07
Measurement of albumin synthesis in humans: a new approach employing stable isotopes. Am J Physiol (1990) 1.05
Subcutaneous growth of human tumours in mice. Nature (1973) 1.05
Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease. Int J Cancer (1978) 1.05
Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer. Br J Surg (1998) 1.04
Enterolith obstruction of the small bowel. J R Coll Surg Edinb (1985) 1.04
Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity. Biochem Pharmacol (1984) 1.03
Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer (1999) 1.02
A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer Group. Acta Oncol (1989) 1.02
Outcome in colorectal adenocarcinoma: two seven-year studies of a population. BMJ (1993) 1.02
Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage. Br J Sports Med (1990) 1.01
Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res (2000) 1.01
Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. Br J Cancer (1981) 1.01
Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr (2005) 1.00
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat (2010) 1.00
Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol (1996) 1.00
Estimation of plasma volume changes during marathon running. Br J Sports Med (1985) 1.00
Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett (2002) 1.00
Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye (Lond) (1990) 0.99
Subungual malignant melanoma: clinicopathological features of 100 cases. Histopathology (1991) 0.99
Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet (1991) 0.98
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. Transplantation (1989) 0.98
N-Acetyl-beta-D-glucosaminidase levels and diabetic microangiopathy. Clin Chim Acta (1979) 0.98
Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo. Gene Ther (2004) 0.98
Carcinoid tumour of the gall bladder: two case reports and a review of published works. Gut (1993) 0.98
Training for minor surgery in general practice: is it adequate? J R Coll Surg Edinb (1997) 0.98
Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr (1994) 0.98
Haemangiopericytoma of the greater omentum. Eur J Surg Oncol (1995) 0.97
Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg (1998) 0.97
Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancer. J Immunother (1991) (1992) 0.96
Characterisation of macrophages infiltrating human mammary carcinomas. Br J Cancer (1985) 0.96
Characterization of the phagocytic cells isolated from the human placenta. J Reticuloendothel Soc (1982) 0.96
Bio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicin. J Drug Target (2007) 0.95
Optimal conditions for the growth of malignant human and animal cell populations in immunosuppressed mice. Cancer Res (1975) 0.95
A toxicological study in rats receiving immunotherapeutic doses of cyclosporin A. Transplantation (1981) 0.95
Characterization of the human natural killer (NK) cell in blood and lymphoid organs. Int J Cancer (1978) 0.94